Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MERCY: Continuous vs Intermittent Meropenem in Sepsis
NCT03452839Phase 4Completed
- Sponsor
- Vita-Salute San Raffaele University
- Start
- Jun 2018
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 4 trial of meropenem in sepsis, septic shock, sponsored by Vita-Salute San Raffaele University. Started Jun 2018; status: completed.
02
Drugs
meropenem
03
Conditions
sepsisseptic shock
Beyond the preview
Go deeper on NCT03452839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03452839.